CNS vs BANF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

CNS

38.5
AI Score
VS
BANF Wins

BANF

60.0
AI Score

Investment Advisor Scores

CNS

39score
Recommendation
SELL

BANF

60score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNS BANF Winner
Net Income 76.58M 129.68M BANF
ROE 44.0% 6.6% CNS
ROA 22.0% 0.9% CNS
Total Assets 348.45M 15.08B BANF
Cash 41.23M 1.70B BANF
Free Cash Flow 86.68M 138.34M BANF

Relative Price Performance (Last 90 Days)

CNS 1M: +1.8% · 3M: +12.8% BANF 1M: -1.7% · 3M: +1.4%

Current Technical Phase

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $81.42

BANF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.0 · Price: $112.91

Fundamentals Snapshot

Metric CNS BANF
Market Cap
Forward P/E 20.5 14.4
Trailing P/E 25.0 15.2
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.5%
EPS 3.23 7.41
Dividend Yield 0.03% 0.02%

Frequently Asked Questions

Based on our detailed analysis, BANF is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.